يعرض 1 - 10 نتائج من 27 نتيجة بحث عن '"Patología renal"', وقت الاستعلام: 0.74s تنقيح النتائج
  1. 1
    رسالة جامعية
  2. 2
    رسالة جامعية
  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية

    المصدر: Arbor; Vol. 194 No. 789 (2018); a468 ; Arbor; Vol. 194 Núm. 789 (2018); a468 ; 1988-303X ; 0210-1963 ; 10.3989/arbor.2018.i789

    وصف الملف: text/html; application/pdf; application/xml

    العلاقة: https://arbor.revistas.csic.es/index.php/arbor/article/view/2281/3243Test; https://arbor.revistas.csic.es/index.php/arbor/article/view/2281/3244Test; https://arbor.revistas.csic.es/index.php/arbor/article/view/2281/3245Test; Abdalla, S. A. y Letarte, M. (2006). Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease. Journal of Medical Genetics, 43 (2), pp. 97-110. https://doi.org/10.1136/jmg.2005.030833Test PMid:15879500 PMCid:PMC2603035; Albiñana, V., Bernabeu-Herrero, M. E., Zarrabeitia, R., Bernabéu, C. y Botella, L. M. (2010). Estrogen therapy for hereditary haemorrhagic telangiectasia (HHT): Effects of raloxifene, on Endoglin and ALK1 expression in endothelial cells. Thrombosis and Haemostasis, 103 (3), 525-534.; Ariceta, G., Besbas, N., Johnson, S., Karpman, D., Landau, D., Licht, C. […] y Zimmerhackl, L. B. (2009). Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome. Pediatric Nephrology. 24 (4), pp. 687-696. https://doi.org/10.1007/s00467-008-0964-1Test PMid:18800230; Atkinson, J. P., Liszewski, M. K., Richards, A., Kavanagh, D. y Moulton, E. A. (2005). Hemolytic uremic syndrome: an example of insufficient complement regulation on self-tissue. Annals of the New York Academy of Sciences, 1056 (1), pp. 144-155. https://doi.org/10.1196/annals.1352.032Test PMid:16387683; Botella, L. M., Sánchez-Elsner, T., Sanz-Rodríguez, F., Kojima, S., Shimada, J., Guerrero-Esteo, M. […] y Bernabéu, C. (2002). Transcriptional activation of endoglin and transforming growth factor-beta signaling components by cooperative interaction between Sp1 and KLF6: their potential role in the response to vascular injury. Blood, 100 (12), pp. 4001-4010. https://doi.org/10.1182/blood.V100.12.4001Test; Bourdeau, A., Dumont, D. J. y Letarte, M. (1999). A murine model of hereditary hemorrhagic telangiectasia. The Journal of Clinical Investigation, 104 (10), pp. 1343-1351. https://doi.org/10.1172/JCI8088Test PMid:10562296 PMCid:PMC409846; Campistol, J. M., Arias, M., Ariceta, G., Blasco, M., Espinosa, M., Grinyó, J. M. […] y Rodríguez de Córdoba, S. (2013). An update for atypical haemolytic uraemic síndrome: diagnosis and treatment. A consensus document. Nefrología, 33 (1), pp. 27-45. PMid:23364625; Dragon-Durey, M.-A., Loirat, C., Cloarec, S., Macher, M. A., Blouin, J., Nivet, H. [.] y Frémeaux-Bacchi, V. (2005). Anti-Factor H Autoantibodies Associated with Atypical Hemolytic Uremic Syndrome. Journal of the American Society of Nephrology, 16 (2), pp. 555-563. https://doi.org/10.1681/ASN.2004050380Test PMid:15590760; Dupuis-Girod, S., Ginon, I., Saurin, J. C., Marion, D., Guillot, E., Decullier, E. […] y Faure, F. (2012). Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output. JAMA, 307 (9), pp. 948-955. https://doi.org/10.1001/jama.2012.250Test; Fakhouri, F., Hourmant, M., Campistol, J. M., Cataland, S., Espinosa, M., Gaber, O. […] y Legendre, C. M. (2013). Eculizumab (ECU) Inhibits Thrombotic Microangiopathy (TMA) and Improves Renal Function in Adult Atypical Hemolytic Uremic Syndrome (aHUS) Patients (Pts). Journal of the American Society of Nephrology, 24, pp. 49-50A.; Faughnan, M. E., Palda, V. A., Garcia- Tsao, G., Geisthoff, U. W., McDonald, J., Proctor, D. D. […] y Zarrabeitia, R. (2011). International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. Journal of Medical Genetics, 48 (2), pp.73-87. https://doi.org/10.1136/jmg.2009.069013Test PMid:19553198; Greenbaum L. A., Fila M., Tsimaratos M, Ardissimo, G., Al-Akash, S., Evans, J. […] y Licht, C. (2013). Eculizumab (ECU) Inhibits Thrombotic Microangiopathy (TMA) and Improves Renal Function in Pediatric Atypical Hemolytic Uremic Syndrome (aHUS) Patients (Pts). Journal of the American Society of Nephrology, 24, 821A.; Holers, V. M. (2008). The spectrum of complement alternative pathway-mediated diseases. Immunological Reviews, 223 (1), pp. 300-316. https://doi.org/10.1111/j.1600-065X.2008.00641.xTest PMid:18613844; Jerkic, M., Rodríguez-Barbero, A., Prieto, M., Toporsian, M., Pericacho, M., Rivas-Elena, J. V. […] y López-Novoa, J. M. (2006). Reduced angiogenic responses in adult Endoglin heterozygous mice. Cardiovascular Research, 69 (4), pp. 845- 854. https://doi.org/10.1016/j.cardiores.2005.11.020Test PMid:16405930; Lacombe, P., Lacout, A., Marcy, P. Y., Binsse, S., Sellier, J., Bensalah, M. […] y El-Hajjam, M. (2013). Diagnosis and treatment of pulmonary arteriovenous malformations in hereditary hemorrhagic telangiectasia: An overview. Diagnostic Interventional Imaging, 94 (9), pp. 835-848. https://doi.org/10.1016/j.diii.2013.03.014Test PMid:23763987; Lastres, P., Letamendía, A., Zhang, H., Rius, C., Almendro, N., Raab, U. […] y Bernabéu, C. (1996). Endoglin modulates cellular responses to TGF-beta 1. The Journal of Cell Biology, 133 (5), pp. 1109-1115. https://doi.org/10.1083/jcb.133.5.1109Test; Lebrin, F., Srun, S., Raymond, K., Martin, S., Brink, S. van den, Freitas, C. […] y Mummery, C. (2010). Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia. Nature Medicine, 16 (4), pp. 420-428. https://doi.org/10.1038/nm.2131Test PMid:20364125; Legendre, C. M., Licht, C., Muus, P., Greenbaum, L. A., Babu, S., Bedrosian, C. [.] y Loirat, C. (2013). Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. The New England Journal of Medicine, 368 (23), pp. 2169-2181. https://doi.org/10.1056/NEJMoa1208981Test PMid:23738544; Lemaire, M., Frémeaux-Bacchi, V., Schaefer, F., Choi, M., Tang, W. H., Quintrec, M. Le [.] y Lifton, R. P. (2013). Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome. Nature Genetics, 45 (5), pp. 531-536. https://doi.org/10.1038/ng.2590Test PMid:23542698 PMCid:PMC3719402; Llorca, O., Trujillo, A., Blanco, F. J. y Bernabéu, C. (2007). Structural model of human endoglin, a transmembrane receptor responsible for hereditary hemorrhagic telangiectasia. Journal of Molecular Biology, 365 (3), pp. 694-705. https://doi.org/10.1016/j.jmb.2006.10.015Test PMid:17081563; López-Novoa, J. M. y Bernabéu, C. (2010). The physiological role of endoglin in the cardiovascular system. American Journal of Physiology-Heart and Circulatory Physiology, 299 (4), H959-H974. https://doi.org/10.1152/ajpheart.01251.2009Test PMid:20656886; Mahmoud, M., Upton, P. D. y Arthur, H. M. (2011). Angiogenesis regulation by TGF? signalling: clues from an inherited vascular disease. Biochemical Society Transactions, 39 (6), pp. 1659-1666. https://doi.org/10.1042/BST20110664Test PMid:22103504; Noris, M. y Remuzzi, G. (2009). Atypical hemolytic-uremic syndrome. The New England Journal of Medicine, 361 (17), pp. 1676-1687. https://doi.org/10.1056/NEJMra0902814Test PMid:19846853; Repetto, H. A., Rodríguez de Córdoba, S., Arrizurieta, E., Rivas, M. e Ibarra, C. (2008). Microangiopatía trombótica y Síndrome Urémico Hemolítico. En: Hernando Avenda-o, L. (ed.). Nefrología Clínica (3.ª ed.), pp. 286-297. PMCid:PMC5469964; Ricklin, D., Hajishengallis, G., Yang, K. y Lambris, J. D. (2010). Complement: a key system for immune surveillance and homeostasis. Nature Immunology, 11 (9), pp. 785-797. https://doi.org/10.1038/ni.1923Test PMid:20720586 PMCid:PMC2924908; Rodríguez de Córdoba, S., Esparza Gordillo, J., Goicoechea de Jorge, E., López-Trascasa, M. y Sánchez-Corral, P. (2004). The human complement factor H: functional roles, genetic variations and disease associations. Molecular Immunology, 41 (4), pp. 355-367. https://doi.org/10.1016/j.molimm.2004.02.005Test PMid:15163532; Rodríguez de Córdoba, S., Subías-Hidalgo, M., Pinto, S. y Tortajada, A. (2014). Genetics of atypical Hemolytic Uremic Syndrome (aHUS). Seminars in Thrombosis and Hemostasis, 40, pp. 422-430. https://doi.org/10.1055/s-0034-1375296Test PMid:24799305; Rodríguez de Córdoba, S., Tortajada, A., Harris, C. L. y Morgan, B. P. (2012). Complement dysregulation and disease: from genes and proteins to diagnostics and drugs. Immunobiology, 217 (11), pp. 1034-1046. https://doi.org/10.1016/j.imbio.2012.07.021Test PMid:22964229; Rossi, E., Sanz-Rodríguez, F., Eleno, N., Düwell, A., Blanco, F. J., Langa, C. […] y Bernabéu, C. (2013). Endothelial endoglin is involved in inflammation: role in leukocyte adhesion and transmigration. Blood. 121 (2), pp. 403-415. https://doi.org/10.1182/blood-2012-06-435347Test PMid:23074273; Shovlin, C. L, Guttmacher, A. E., Buscarini, E., Faughnan, M. E., Hyland, R. H., Westermann, C. J. […] y Plauchu, H. (2000). Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler- Weber syndrome). American Journal of Medical Genetics, 91 (1), pp. 66-67. 3.0.CO;2-P" target="_blank">https://doi.org/10.1002Test/(SICI)1096-8628(20000306)91:13.0.CO;2-P; Shovlin, C. L. (2010). Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment. Blood Reviews, 24 (6), pp. 203-219. https://doi.org/10.1016/j.blre.2010.07.001Test PMid:20870325; Srinivasan, S., Hanes, M. A., Dickens, T., Porteous, M. E., Oh, S. P., Hale, L. P. y Marchuk, D. A. (2003). A mouse model for hereditary hemorrhagic telangiectasia (HHT) type 2. Human Molecular Genetics, 12 (5), pp. 473-482. https://doi.org/10.1093/hmg/ddg050Test; Warwicker, P., Goodship, T. H. J., Donne, R. L., Pirson, Y., Nicholls, A., Ward, R. M. […] y Goodship, J. (1998). Genetic studies into inherited and sporadic hemolytic uremic syndrome. Kidney International, 53 (4), pp. 836-844. https://doi.org/10.1111/j.1523-1755.1998.00824.xTest PMid:9551389; Wooderchak-Donahue, W. L., McDonald, J., O'Fallon, B., Upton, P. D., Li, W., Roman, B. L. […] y Bayrak-Toydemir, P. (2013). BMP9 mutations cause a vascular-anomaly syndrome with phenotypic overlap with hereditary hemorrhagic telangiectasia. The American Journal of Human Genetics, 93 (3), pp. 530-537. https://doi.org/10.1016/j.ajhg.2013.07.004Test PMid:23972370 PMCid:PMC3769931; https://arbor.revistas.csic.es/index.php/arbor/article/view/2281Test

  5. 5
    دورية أكاديمية
  6. 6
    دورية أكاديمية
  7. 7
    دورية أكاديمية
  8. 8
    رسالة جامعية

    المؤلفون: Henao Cardona, Angie Fernanda

    المساهمون: Arbeláez Ospina, Alejandra

    مصطلحات موضوعية: Patología renal, Cuidado intensivo, Indicaciones de TRR

    جغرافية الموضوع: Tuluá, Valle del Cauca, Colombia

    وصف الملف: PDF; 24 Páginas; application/pdf

    العلاقة: http://hdl.handle.net/20.500.12993/2917Test; Instname:Unidad Central del Valle del Cauca; reponame:Repositorio Institucional Unidad Central del Valle del Cauca; repourl:https://repositorio.uceva.edu.coTest/

  9. 9
  10. 10